Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The chequered history of malaria control: are new and better tools the ultimate answer?

Annals of tropical medicine and parasitology·2007
Same author

The HF epidemic: the need for new treatment strategies.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Same author

Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2006
Same author

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

Antimicrobial agents and chemotherapy·2005
Same author

Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.

Acta tropica·2003
Same author

Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.

Journal of medicinal chemistry·2001

相关实验视频

Updated: Jun 26, 2026

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

梅花素 (WR 142,490) 用于治疗人类疟疾.

C M Trenholme, R L Williams, R E Desjardins

    Science (New York, N.Y.)
    |November 21, 1975
    PubMed
    概括

    梅花素化有效地治疗了志愿者的疟疾. 这种新药对抗抗克洛洛昆抗性Plasmodium falciparum菌株表现出显著活性,为抗药性疟疾提供了一个有希望的替代品.

    科学领域:

    • 药理学 药理学是指药理学的学科.
    • 传染性疾病 传染性疾病
    • 热带医学 热带医学

    背景情况:

    • 疟疾仍然是一个重大的全球卫生挑战.
    • 抗药性Plasmodium falciparum菌株需要新的治疗剂.
    • 氨酸耐药性是疟疾治疗中日益关注的一个问题.

    研究的目的:

    • 为了评估梅弗洛基因化作为单剂量口服治疗疟疾的疗效和安全性.
    • 为了评估美弗洛对敏感和耐药的Plasmodium falciparum感染的活性.

    主要方法:

    • 47名感染疟疾的志愿者接受了单次口服甲floquine化剂的治疗.
    • 对发烧,寄生虫血症和复发的治疗结果进行了监测.
    • 专门评估了非免疫性疟疾患者的疗效.

    主要成果:

    • 在所有接受治疗的志愿者中,梅花素化迅速清除了发烧和寄生病.
    • 没有观察到寄生虫在患有对黄素敏感感染的患者中复发.
    • 梅弗洛奎因对抗抗克洛洛奎因抗性Plasmodium falciparum具有很高的疗效,治愈率为83% (1g剂量) 和100% (1.5g剂量).

    更多相关视频

    Medicated Thread Moxibustion Therapy of Zhuang Medicine and its Application in a Rat Model of Cold-Congealing Syndrome of Primary Dysmenorrhea
    04:35

    Medicated Thread Moxibustion Therapy of Zhuang Medicine and its Application in a Rat Model of Cold-Congealing Syndrome of Primary Dysmenorrhea

    Published on: January 19, 2024

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
    08:36

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

    Published on: April 19, 2024

    相关实验视频

    Last Updated: Jun 26, 2026

    Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
    04:47

    Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

    Published on: October 27, 2023

    Medicated Thread Moxibustion Therapy of Zhuang Medicine and its Application in a Rat Model of Cold-Congealing Syndrome of Primary Dysmenorrhea
    04:35

    Medicated Thread Moxibustion Therapy of Zhuang Medicine and its Application in a Rat Model of Cold-Congealing Syndrome of Primary Dysmenorrhea

    Published on: January 19, 2024

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
    08:36

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

    Published on: April 19, 2024

    结论:

    • 梅弗洛昆化在治疗疟疾方面是有效的,包括耐克洛昆的感染.
    • 单剂量梅弗洛显示出作为治疗耐药疟疾的重要潜力.
    • 这种药物可能为挑战性疟疾病例的现有疗法提供一种有价值的替代品.